Table 3

Health outcome stratified by diabetes treatment beliefs

Mean (CI)HbA1c, % and mmol/molp ValueNSystolic BP, mm Hgp ValueNs-Cholesterol, mmol/Lp ValueNLDL, mmol/Lp ValueN
Finding the treatment cumbersome
 No7.4 (6.4 to 8.6); 57 (46 to 70)<0.001573132.5 (119.5 to 145.7)0.4174234.0 (3.2 to 5.0)0.3645861.9 (1.3 to 2.8)0.346569
 Neutral7.8 (6.7 to 9.2); 62 (50 to 77)161131.7 (105.6 to 159.0)1034.1 (3.2 to 5.1)1591.9 (1.3 to 2.8)155
 Yes7.8 (6.5 to 9.3); 62 (48 to 78)124130.3 (98.2 to 161.9)864.1 (3.2 to 5.3)1302.0 (1.4 to 3.0)127
Perceived low treatment efficacy
 No7.4 (6.4 to 8.6); 57 (46 to 70)<0.001661132.3 (119.9 to 144.9)0.2174744.0 (3.2 to 5.0)0.0636781.9 (1.3 to 2.8)0.573658
 Neutral7.9 (6.7 to 9.5); 63 (50 to 80)88133.7 (105.4 to 161.1)614.2 (3.2 to 5.5)862.0 (1.4 to 2.9)82
 Yes7.8 (6.5 to 9.3); 62 (48 to 78)98129.5 (92.6 to 166.9)714.1 (3.3 to 5.0)1001.9 (1.3 to 2.9)100
Technical HbA1c understanding
 Yes7.5 (6.5 to 8.7); 58 (48 to 72)0.483325132.6 (113.7 to 151.3)0.9252444.1 (3.3 to 5.0)0.2423192.0 (1.3 to 2.8)0.344318
 No7.5 (6.4 to 8.8); 58 (46 to 73)432132.7 (117.8 to 148.1)2994.0 (3.2 to 5.1)4221.9 (1.3 to 2.8)419
Satisfactory HbA1c level
 7.5% or below7.4 (6.4 to 8.6); 57 (46 to 70)<0.001676132.0 (119.6 to 144.9)0.9274804.0 (3.2 to 5.1)0.8406651.9 (1.3 to 2.8)0.690661
 Above 7.5%8.0 (6.8 to 9.4); 64 (51 to 79)140132.2 (104.2 to 160.8)984.0 (3.3 to 5.0)1342.0 (1.4 to 2.8)134
 Do not know7.7 (6.4 to 9.3); 61 (46 to 78)81133.2 (92.8 to 175.3)614.0 (3.2 to 5.1)881.9 (1.3 to 2.7)87
  • Estimates from analysis of covariance adjusted for (1) insulin regimen, smoking, age, duration of diabetes, (2) age and self-reported NYHA class, (3) age and gender, and (4) insulin regimen and gender. Geometric means are shown for log-transformed data (HbA1c, s-cholesterol and LDL).

  • BP, blood pressure; HbA1c, glycated hemoglobin; LDL, low-density lipoprotein; NYHA, New York Heart Association.